A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control
- PMID: 16308569
- PMCID: PMC1356322
- DOI: 10.1038/sj.emboj.7600874
A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control
Retraction in
-
Retraction. A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control.EMBO J. 2011 Feb 2;30(3):627. doi: 10.1038/emboj.2011.7. EMBO J. 2011. PMID: 21285977 Free PMC article. No abstract available.
Abstract
Discrimination between cytokine receptor and receptor tyrosine kinase (RTK) signaling pathways is a central paradigm in signal transduction research. Here, we report a 'promiscuous liaison' between both receptors that enables interleukin (IL)-15 to transactivate the signaling pathway of a tyrosine kinase. IL-15 protects murine L929 fibroblasts from tumor necrosis factor alpha (TNFalpha)-induced cell death, but fails to rescue them upon targeted depletion of the RTK, Axl; however, Axl-overexpressing fibroblasts are TNFalpha-resistant. IL-15Ralpha and Axl colocalize on the cell membrane and co-immunoprecipitate even in the absence of IL-15, whereby the extracellular part of Axl proved to be essential for Axl/IL-15Ralpha interaction. Most strikingly, IL-15 treatment mimics stimulation by the Axl ligand, Gas6, resulting in a rapid tyrosine phosphorylation of both Axl and IL-15Ralpha, and activation of the phosphatidylinositol 3-kinase/Akt pathway. This is also seen in mouse embryonic fibroblasts from wild-type but not Axl-/- or IL-15Ralpha-/- mice. Thus, IL-15-induced protection from TNFalpha-mediated cell death involves a hitherto unknown IL-15 receptor complex, consisting of IL-15Ralpha and Axl RTK, and requires their reciprocal activation initiated by ligand-induced IL-15Ralpha.
Figures









Similar articles
-
Gas6 attenuates lipopolysaccharide‑induced TNF‑α expression and apoptosis in H9C2 cells through NF‑κB and MAPK inhibition via the Axl/PI3K/Akt pathway.Int J Mol Med. 2019 Sep;44(3):982-994. doi: 10.3892/ijmm.2019.4275. Epub 2019 Jul 12. Int J Mol Med. 2019. PMID: 31524235 Free PMC article.
-
Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase.Mol Cell Biol. 1996 Jan;16(1):135-45. doi: 10.1128/MCB.16.1.135. Mol Cell Biol. 1996. PMID: 8524290 Free PMC article.
-
Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer.Cancer Res. 2011 Mar 1;71(5):1792-804. doi: 10.1158/0008-5472.CAN-10-2186. Epub 2011 Feb 22. Cancer Res. 2011. PMID: 21343401
-
Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily.FEBS J. 2006 Dec;273(23):5231-44. doi: 10.1111/j.1742-4658.2006.05529.x. Epub 2006 Oct 25. FEBS J. 2006. PMID: 17064312 Review.
-
Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases.Cytokine Growth Factor Rev. 2006 Aug;17(4):295-304. doi: 10.1016/j.cytogfr.2006.04.004. Epub 2006 Jun 5. Cytokine Growth Factor Rev. 2006. PMID: 16737840 Review.
Cited by
-
The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development.Blood. 2009 Mar 12;113(11):2470-7. doi: 10.1182/blood-2008-05-157073. Epub 2008 Oct 7. Blood. 2009. PMID: 18840707 Free PMC article.
-
Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors.J Cell Mol Med. 2007 Sep-Oct;11(5):1012-30. doi: 10.1111/j.1582-4934.2007.00120.x. J Cell Mol Med. 2007. PMID: 17979880 Free PMC article. Review.
-
AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma.Cancers (Basel). 2019 Nov 5;11(11):1727. doi: 10.3390/cancers11111727. Cancers (Basel). 2019. PMID: 31694201 Free PMC article. Review.
-
Immunobiology of the TAM receptors.Nat Rev Immunol. 2008 May;8(5):327-36. doi: 10.1038/nri2303. Nat Rev Immunol. 2008. PMID: 18421305 Free PMC article. Review.
-
Retraction. A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control.EMBO J. 2011 Feb 2;30(3):627. doi: 10.1038/emboj.2011.7. EMBO J. 2011. PMID: 21285977 Free PMC article. No abstract available.
References
-
- Allen MP, Zeng C, Schneider K, Xiong X, Meintzer MK, Bellosta P, Basilico C, Varnum B, Heidenreich KA, Wiermann ME (1999) Growth arrest-specific gene 6 (Gas6)/adhesion related kinase (Ark) signaling promotes gonadotropin-releasing hormone neuronal survival via extracellular signal-regulated kinase (ERK) and Akt. Mol Endocrinol 13: 191–201 - PubMed
-
- Bellosta P, Zhang Q, Goff SP, Basilico C (1997) Signaling through the Ark tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation. Oncogene 15: 2387–2397 - PubMed
-
- Bennasroune A, Gardin A, Aunis D, Cremel G, Hubert P (2004) Tyrosine kinase receptors as attractive targets of cancer therapy. Crit Rev Oncol Hematol 50: 23–38 - PubMed
-
- Brandt K, Bulfone-Paus S, Foster DC, Rückert R (2003) Interleukin-21 inhibits dendritic cell activation and maturation. Blood 102: 4090–4098 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous